Detailed Abstract
[E-poster]
[E24] Current trends in the types of pancreatoduodenectomy focusing on the role of robot-assisted pancreatoduodenectomy
Mirang LEE1 , Jin-Young JANG*1 , Youngmin HAN1 , Young Jae CHO1 , Hye-Sol JUNG1 , Won-Gun YUN1 , Wooil KWON1
1 Department Of Surgery And Cancer Research Institute, Seoul National University College Of Medicine, REPUBLIC OF KOREA
Background : Pancreatoduodenectomy (PD) is the most challenging abdominal surgery requiring elaborate and strenuous procedures. In spite of popularization of laparoscopic procedure for the most of gastrointestinal surgery, laparoscopic PD is not so widely spread. However, the popularity of robotic PD has recently increased due to many advantages. So we investigated current trends of types of PD and the clinical role of robotic surgery.
Methods : Between January 2015 and June 2022, a total of 1658 PD was performed. 1120 patents underwent open PD, and 538 underwent robotic PD. Demographics and surgical outcomes were analyzed according to time period (first and late half period), and propensity score-matched (PSM) analysis was performed to evaluate complications and oncologic outcomes.
Results : Patients undergoing robotic PD were younger (robot vs. open PD: 63.4 vs. 65.4 years, P =0.002); however, no significant intergroup difference was observed in sex (P = 0.310) and body mass index (P = 0.206). Patients who underwent robotic PD were more likely to have benign disease (30.2%) than those who received open surgery(13.7%). Robot PD has gradually increased from 6.3% to 71.6%. Operation time was longer in the robot group (327.0 vs. 293.5 min, P < 0.001); however, estimated blood loss did not significantly differ (523.9 vs. 564.6 mL, P = 0.237). Complications of C-D grade 3a or higher (21.0% vs. 19.0%, P = 0.341) and CR-POPF rates (10.0% vs. 9.3%, P =0.626) were similar. Hospital stay was shorter in robot PD (11.1 days) than open PD (15.0 days). After PSM analysis, no significant difference of morbidity and survival outcome in cancer patients was observed in open and robot PD.
Conclusions : The number of robot PD has markedly increased in a relative short time showing comparable morbidity/mortality and oncologic outcome. Considering better recovery and cosmetic outcome, robot PD has become one of standard surgical method in pancreatic surgery.
Methods : Between January 2015 and June 2022, a total of 1658 PD was performed. 1120 patents underwent open PD, and 538 underwent robotic PD. Demographics and surgical outcomes were analyzed according to time period (first and late half period), and propensity score-matched (PSM) analysis was performed to evaluate complications and oncologic outcomes.
Results : Patients undergoing robotic PD were younger (robot vs. open PD: 63.4 vs. 65.4 years, P =0.002); however, no significant intergroup difference was observed in sex (P = 0.310) and body mass index (P = 0.206). Patients who underwent robotic PD were more likely to have benign disease (30.2%) than those who received open surgery(13.7%). Robot PD has gradually increased from 6.3% to 71.6%. Operation time was longer in the robot group (327.0 vs. 293.5 min, P < 0.001); however, estimated blood loss did not significantly differ (523.9 vs. 564.6 mL, P = 0.237). Complications of C-D grade 3a or higher (21.0% vs. 19.0%, P = 0.341) and CR-POPF rates (10.0% vs. 9.3%, P =0.626) were similar. Hospital stay was shorter in robot PD (11.1 days) than open PD (15.0 days). After PSM analysis, no significant difference of morbidity and survival outcome in cancer patients was observed in open and robot PD.
Conclusions : The number of robot PD has markedly increased in a relative short time showing comparable morbidity/mortality and oncologic outcome. Considering better recovery and cosmetic outcome, robot PD has become one of standard surgical method in pancreatic surgery.
SESSION
E-poster
E-Session 09/16 ALL DAY